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Abstract 
 
Background/Aim. In the new millennium, the focus has been in-
creasingly shifting to optimisation by enhancing the collaborative 
(common, joint) practice of healthcare professionals, for the purpose 
of achieving effectiveness and efficiency. Pharmacists are the last link 
in the healthcare services providing chain. The aim of this study was 
to present a critical analysis of the published models of the collabora-
tive pharmacy practice along with development of a conceptual 
model of collaborative pharmacy practice in the healthcare and social 
care for the elderly population. Methods. Using two search algo-
rithms that were created to search articles published in English, a 
comprehensive search of the bibliographic databases Web of Science 
and PubMed was undertaken (up to June 2015). Afterwards, articles 
were independently assessed by two authors, against predetermined 
inclusion and exclusion criteria. Results. Regulations on pharmacy 
collaboration are present in many developed countries. However, the 
implementation of the collaborative practice is still not widespread. 
Therefore, a conceptual model of the collaborative healthcare and 
social care of the elderly provides an insight into a multi-layer struc-
ture that has to be established in order to achieve a functioning sys-
tem of the collaborative healthcare practice. The model concluded 
that aspirations towards teamwork, communication and above all – 
the system of regulators and payers, who acknowledge a healthcare 
collaboration, are crucial for establishment of a collaborative health-
care practice. Conclusion. This research provides a tool in the form 
of a guide and check-list for decision-makers and policy-makers in 
order to achieve the preferred effects generated from the collabora-
tive practice by selecting the models and activities that need to be 
undertaken for implementation of the collaborative healthcare and 
social care of the elderly that is best suited for their country. 
 
Key words:  
delivery of health care; pharmacists; interdisciplinary 
communication; aged. 
Apstrakt 
 
Uvod/Cilj. U cilju postizanja efektivnosti i efikasnosti, u no-
vom milenijumu se sve više govori o optimizaciji zdravstvene 
zaštite, kroz jačanje udružene prakse zdravstvenih profe-
sionalaca. Farmaceuti predstavljaju poslednju kariku u lancu 
pružanja zdravstvene zaštite. Cilj ove studije bio je da prikaže 
kritičku analizu publikovanih modela kolaborativne farmaceut-
ske prakse, kao i razvoj konceptualnog modela farmaceutske 
kolaborativne prakse u zdravstvenoj i socijalnoj zaštiti starije 
populacije. Metode. Koristeći dva algoritma koja su kreirana za 
pretragu, pretraženi su radovi (do juna 2015. godine) iz biblio-
grafija elektronskih baza podataka Web of Science i PubMed. 
Nakon pretrage, radovi su nezavisno procenjeni u odnosu na 
predefinisane kriterijume za uključenje i isključenje, od strane 
dva autora. Rezultati. Regulativa o farmaceutskoj kolaboraciji 
je zastupljena u mnogim razvijenim zemljama. Međutim, 
implementacija kolaborativne prakse još uvek nije široko 
rasprostranjena. Stoga, konceptualni model kolaborativne 
farmaceutske prakse u zdravstvenoj i socijalnoj zaštiti starijih 
osoba obezbeđuje uvid u višeslojnu strukturu koja treba biti 
uspostavljena kako bi se osigurao funkcionalni sistem 
kolaborativne zdravstvene prakse. Model zaključuje da su 
aspiracije prema timskom radu, komunikacija i nadasve sistem 
regulatora i platioca koji prepoznaju zdravstvenu kolaboraciju, 
ključni za uspostavljanje kolaborativne zdravstvene prakse. 
Zaključak. Ovo istraživanje donosi alat u obliku vodiča i ček-
liste za donosioce odluka i regulativa, kako bi se istim 
omogućilo da postignu preferirane efekte prikupljenih 
kolaborativnih praksi, kroz označavanje modela i aktivnosti 
koje treba preduzeti za implementaciju one kolaborativne 
zdravstvene i socijalne zaštite starijih osoba koji su 
najprimenjiviji u njihovoj zemlji. 
 
Ključne reči: 
zdravstvena zaštita; farmaceuti; komunikacija, 
interdisciplinarna; stare osobe. 
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Introduction 
Despite the common interest in optimising the work and 
minimising the potential risks to patients, general practitio-
ners and pharmacists generally strived to work independently 
with a minimal inter-professional contact in the past 1. Fur-
thermore, the relationship between the general practitioners 
and pharmacists was often described as being historically 
conflicting and rivalling, with major tensions associated with 
the commercial aspect of the open-type pharmacies 2. 
Some papers 3–9 emphasise the need for communication 
and collaboration among healthcare professionals, for the 
purpose of ensuring much needed continuity and coordina-
tion in healthcare, all towards securing the most favourable 
outcome for patients. Taking into account the presence of a 
growing ageing population on the global level as well as the 
increased health and social problems the elderly are facing, it 
is suggested that future efforts of the healthcare and social 
care systems should be focused on ensuring the most ade-
quate meeting of growing demand heading their way 10. 
There is a consensus among the authors dealing with social 
pharmacy of the idea that healthcare and social care systems 
should be approached holistically. Similarly to such a para-
digm, there is indeed an increase in the importance of pro-
motion and enhancement of the models of collaborative 
healthcare and social practice, with particular focus on the 
elderly, as a particularly vulnerable group. In this respect, in 
the past ten years and simultaneously with improvement of 
the collaborative practice, there was a number of studies pub-
lished 5–9, which have attempted to explain healthcare and 
social dimensions of the collaborative practice in an in-
sufficiently empirical manner, according to some authors. 
Alongside with increased number of publications which 
have their focus on the healthcare collaborative practices, 
there was an increased number of attempts to apply the ideas 
given in aforementioned publications. In Serbia, for example, 
some pharmaceutical services described in the Regulation of 
healthcare services nomenclature at primary healthcare, 
should be provided in collaboration with physicians 11. Some 
of those services are: informing healthcare professionals by 
pharmacist about rational prescribing and use of medications 
and medical devices according to approved indications, cur-
rent therapy guidelines, new knowledge about side effects, or 
market withdrawals of medications and medical devices, 
pharmaceutical waste collection and classification, etc. How-
ever, a payment model for appropriate reimbursement of 
pharmaceutical services still does not exist in Serbia. 
When considering the collaboration of healthcare and 
social care systems intended for the elderly, it is impossible 
not to focus, first of all, on the inter-professional collabora-
tion within the system and then between the two systems 
specified. Due to the fact that collaboration between health-
care and social care systems is covered by the literature 
(from the healthcare towards the social care system), in this 
paper, the emphasis will be placed on the healthcare practice 
first, to be followed by the healthcare and social care col-
laboration practice. 
In 2003, the Ministry of Health of England initiated that 
issue and started devising the collaborative practice, with a 
vision that an open-type pharmacy should be recognised as 
an integral part of the National Health Service (NHS), and 
that pharmaceutical services should be better integrated in 
business operations of other providers of services belonging 
to the primary level of healthcare – the physicians in par-
ticular 12. In 2005, that was followed by an introduction of 
conceptual changes for pharmacists, which were aimed at ex-
tending the role of pharmacists by ensuring their greater in-
volvement in consultation services, which included the co-
operation with physicians 13. Then in 2008, the Department 
of Health in England stated that collaboration between phar-
macists and physicians had not been developing at the ex-
pected pace and investment of additional efforts would be 
required in the future in order to ensure the proper course of 
the collaborative concept 14. 
The collaborative system of healthcare is focused on a 
team approach to providing healthcare services to individuals 
and their families, which would eventually result in a higher 
level of continuous healthcare 15. Its roots and development 
go back to the period of World War II, when healthcare pro-
fessionals cooperated with each other and joined efforts to 
ensure proper treatments and cure for wounded soldiers 3. 
Nevertheless, the adoption of this approach was delayed, due 
to an absence of laws and regulations, resistance of health-
care providers who felt threatened as well as a lack of any 
sort of compensation/reimbursement to third parties in such a 
healthcare system. 
In Denmark, decision-makers and representatives of the 
country`s authorities have assumed a much needed political 
initiative to integrate all stakeholders within the system of 
social care and healthcare for the elderly in the last ten years. 
The political initiatives resulted in concrete administrative 
regulations. Such policy aims (emphasised by focusing the 
overall systemic efforts on the care for the elderly) represents 
the integral structure of reforms in the local community (mu-
nicipalities). Described reforms included evaluation of the 
health and social status of elderly people in their homes, 
which was carried out by interdisciplinary teams, which 
would then initiate some improvements to the existing situa-
tion after the evaluation [Patient Centred Medical Home 
(PCMH) a collaborative practice model]. The efficiency of 
the activities specified above confirmed the necessity of a 
joint, collaborative action of both healthcare and social sec-
tors, for the purpose of enhancing an adequate healthcare and 
social care 5. As soon as the evidence started suggesting the 
interrelation between the absence of a continuous, coordi-
nated and collaborated healthcare and negative outcomes, the 
collaborative practice among the healthcare workers of dif-
ferent professions has become a national target. A new, 
team-based approach connects healthcare professionals such 
as physicians, pharmacists and nurses. This approach of in-
terdisciplinary collaborative teams provides the availability 
of patient information to all healthcare workers 16. That way, 
they become aware of the overall expectations of patients in 
terms of the most positive outcome as well as of the expec-
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tations of other healthcare employees, to provide, altogether, the 
full healthcare services and monitor them within the system.  
The previous examples and theoretical considerations 
of issues of collaborative pharmacy practice in a modern so-
ciety are very challenging to researchers, requiring a critical 
approach in the analysis of the published models of collabo-
rative pharmacy practice. The purpose of this paper is to give 
a critical analysis of the proposed models of collaborative 
practice in the healthcare of the elderly population. Addi-
tionally, the paper contains a proposed conceptual model of 
the collaborative pharmacy practice in healthcare and social 
care of elderly population. 
Methods 
A comprehensive search of the bibliographic data-
bases Web of Science and PubMed was undertaken (up to 
June 2015). Two search algorithms have been created by 
using combination of Medical Subject Headings (MeSH) 
and free-text with following Boolean operators: i) [col-
laborative *near/5 model* AND healthcare (MeSH)] OR 
[physician (MeSH) AND pharmacist (MeSH)] AND [so-
cial care AND healthcare (MeSH)] AND [elderly (MeSH) 
OR older people] OR [collaboration and *geriatrics* 
(MeSH)]; ii) [collaboration AND pharmacist (MeSH)] 
AND [physician (MeSH) OR general practitioner] AND 
(model OR relationship).  
The desk analysis was used to search for all English 
language articles using the aforementioned databases. In or-
der to select all potentially eligible publications, two review-
ers (VOI, VM), assessed independently their title, abstracts 
and full text against following predetermined inclusion and 
exclusion criteria (Table 1). 
After independent reading of two authors, records that 
did not fit inclusion and exclusion criteria were discarded. 
Any disagreement between reviewers was resolved by dis-
cussion and consensus. 
The literature search (Figure 1) initially yielded 676 ar-
ticles (Web of Science, n = 201; PubMed, n = 475). After 
removing 108 identified duplicates, 568 potentially relevant 
studies were remained for further screening. After screening, 
535 publications were excluded based on their title and ab-
stract. There were 7 publications that had unobtainable full 
copies. After 26 full copies assessed for eligibility and 7 pub-
lications additionally added through manual search of refer-
ence list, 23 publications were excluded after full copy 
screening. Once being assessed against inclusion and exclu-
sion criteria, 10 articles remained. 
Exploration and consideration was done in accordance to 
its contribution to development of the collaborative healthcare 
models: Disease Management (DM), Medication Therapy Man-
agement (MTM), PCMH and Accountable Care Organisations 
(ACO). A dynamic conceptual model of collaborative health 
care and collaborative pharmacy practice in healthcare and so-
cial care of the elderly was generated for better understanding of 
positive and negative effects on collaborative healthcare models, 
and for creating a guidebook for implementation of collabora-
tive models into a healthcare system.  
Results and discussion 
Development of a conceptual model of collaborative 
healthcare and collaborative pharmacy practice in 
healthcare and social care for the elderly 
The term of collaborative pharmacy practice is defined in 
different ways. As pharmacists are focused mainly on ad-
ministering medications prescribed by the physicians, it can be 
said that the collaborative practice between pharmacists and 
physicians (and vice versa) is only sporadic, until the point when 
the patient`s security and positive outcomes became a dominant 
focus of the entire healthcare system. Being focused on medica-
tions is in the nature of the pharmacy profession, and that very 
focus has led to defining and creating examples of the collabora-
tive pharmacy practice oriented towards the collaborative prac-
tice between physicians and pharmacists.  
The collaborative practice that also involves pharma-
cists gradually gained impetus with support of regulatory 
bodies and positive evidence. The Collaborative Practice Act 
(CPA), extending to 46 USA states, allows pharmacists to 
start a voluntary collaboration with physicians and other 
healthcare service providers, in order to be able to provide a 
full set of healthcare services to patient 17. In most US states, 
there are no special or additional requirements for joining 
that sort of agreements,  besides owning a licence. Still, in 
several states of the USA, the American Society of Health-
System Pharmacists (ASHP) requires a certain number of 
years (years of service) spent working at a clinic or a similar 
health facility upon finalising the licencing procedure. 
Table 1 
Inclusion and exclusion criteria 
Inclusion criteria:  
i. Language: 
ii. Type of study:  
iii. Processes analysed:  
 
 
iv. Team structure:  
English. 
Qualitative and quantitative study. 
Inter-professional work, collaboration, attitudes towards team work, collabo-
rative models, payment models and systems, system and legislative barriers, 
healthcare and social care services for the elderly. 
At least one pharmwacist involved in a multidisciplinary team or collabora-
tive process.  
 
Exclusion criteria: Studies focused solely on the quantification of the inappropriate prescribing of drugs and inci-
dence of dispensing errors. 
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Fig. 1 – Literature search pathway. 
 
 
The collaborative practice of pharmacists and physi-
cians is focused on a medication therapy management, ther-
apy adjustment, patient consultation, and eventually, identi-
fication, elimination and prevention of any interactions be-
tween medications or a drug-food interaction. Most 
forms/types of the collaborative practice involve pharmacists 
cooperating with one or several physicians, in the 
clinic/dispensary or hospital practice, i.e., some form of 
clinical healthcare or similar activity. Pharmacists in other 
countries have arrangements (agreements or contracts) with 
physicians similar to the CPA; in Quebec, Canada, for ex-
ample, pharmacists are allowed to initiate and change the 
therapy prescribed by a physician as well as to demand labo-
ratory analyses, if considered necessary 6. Hence, the col-
laborative pharmacy practice may be understood as a physi-
cians and pharmacists team gathering primarily (whether col-
located or not) around the same goal, i.e., the best possible 
outcome for the patient. Before establishing any collabo-
rative practice, healthcare professionals certainly need to 
show their willingness to overcome the traditional communi-
cation and inter-professional barriers (by changing their at-
titude about the exclusive professional work independence). 
It is also necessary to have a legislative, political and eco-
nomic will to support such inter-professional association (by 
developing a legislative and economic infrastructure through 
implementation of regulations and payment modalities).  
Due to the fact that the literature 7–8 present the four 
most represented models of healthcare and social collabora-
tive practice, it is relevant to start analysing them in order to 
see the advantages and limitations of the described models. 
The static nature of these models is evident from the very 
beginning. Although Bradley et al. 7 explained in detail all 
the phases and activities that precede collaboration, very lit-
tle attention was paid to the dynamics of collaborative rela-
tions through particular collaborative models that were al-
ready operational in the collaborative practice of several de-
veloped countries. In addition, visibility of individuals (pa-
tient and healthcare professional`s point of view) in collabo-
rative models is quite infrequent, despite a growing number 
of authors who have recently described four most repre-
sented models of the collaborative healthcare practice (the 
MTM, primarily). In this regard, our team of authors agrees 
that it is necessary to conduct a further analysis of the four 
most operative models of healthcare and social practice from 
the perspective of the service provider, as well as the per-
spective of patients/elderly people and the system/payers.  
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It may be noted in Tables 2a and 2b that there are positive 
and negative aspects in each model of the collaborative practice 
as well as different aspirations of the involved participants to-
wards team pooling. Harmonisation of diversity of aspirations 
among different participants in a collaborative practice as well 
as development of solutions based on compromise are the great-
est challenges in organising the collaborative models in the prac-
tice of one country. Accordingly, the significance of understand-
ing of each model by different providers of health and social 
care services is equally invaluable as by patients/elderly people 
and system/payers. In addition, the aforementioned models of 
collaborative practice in the healthcare and social care of elderly 
people are organised at different locations. Therefore, it would 
be beneficial to designate the places, where particular models of 
collaborative practice are organised, or locations and health fa-
cilities a patient needs to visit in order to receive the healthcare 
(or healthcare and social care services) within a collaborative 
practice model. Thus, new questions have emerged as well as 
the willingness to figure out the adequate responses after con-
ducting a detailed analysis of the existing models. This ambition 
resulted in creating an idea and a need for conceptualising a new 
model, which would enable providing clear guidelines for the 
planned, gradual introduction of collaborative models into a 
practice of any country, by ensuring a profession-based connec-
tion of collaborative models and creating a dynamic model. 
Table 2a 
Analysis of the most represented healthcare and social collaborative practice models  
– perspective of service providers 
Collaborative prac-
tice models 
Scope of the 
model Physician Pharmacist Social worker 
 
 
Organisations of healthcare providers that agree on the payment based on the perform-
ance of services provided. Such organisations focus on the most positive outcomes for 
their patients and function within the Medicare programme. 
+ 
 
Most optimal outcomes 
for the patient. Shared 
responsibility. 
Acknowledgment of all addi-
tional services provided to the 
patient.  
Involvement of a third 
party for payment. Pri-
vate funds. 
 
ACO 
(organisations of 
healthcare 
providers) 
- 
 
More time consuming. If 
the level of performance 
is not met, payment is 
disputed.  
Due to shared responsibility, the 
setting is team-oriented, but 
more effort invested in own ser-
vices. Team autonomy in part. 
Model not available to 
all patients. Lesser in-
volvement of social 
workers.  
 
 
Focused on a team, collocated therapy for chronic diseases. Developed as a result of a 
lack of physicians. Includes teams composed of physicians, pharmacists, social work-
ers, nurses, carers, nutritionists, etc. Provides outpatient services mainly. 
+ 
 
Increased trust in col-
leagues owing to the 
team spirit. More optimal 
outcomes.  
Increased quality of the pro-
vided service through a holistic 
approach to the patient’s condi-
tion. 
High and direct en-
gagement of social 
workers. Assessment 
of the social status. 
PCMH 
(healthcare services 
provided at pa-
tient’s home) 
- Necessity of having a 
clear plan for service 
provision (according to 
items on the list). 
Visiting patients on site. Loss of 
time. Necessity for recognising 
the model by the state pro-
gramme. 
Higher patient selectiv-
ity compared to the so-
cial status. 
 
 
Medication Therapy Management including greater involvement of pharmacists in pa-
tient’s therapy, both in pharmacies and on site. It includes: analysis of medication ther-
apy, pharmacotherapeutic consultation, anticoagulation therapy management, immuni-
sation, health and wellness programmes. 
+ 
 
Delegating responsibility 
and trust to the pharma-
cist. 
Therapy management for sev-
eral chronic diseases. Person in 
charge of therapy prescription. 
Respect and trust.  
Higher savings for the 
social care system. 
MTM 
 
 
- 
 
Taking away a part of 
autonomy. Frequent col-
location.  
Payment models and economic 
acknowledgement of additional 
services. 
Non-inclusion of social 
workers. 
 Education of patients about medications, continuous monitoring (by the physician and 
pharmacist) of patients with highly prevalent chronic conditions; in case of several 
treatment modalities; a possibility of self-care; carrying a significant economic burden. 
Multiway communication. 
+ 
 
Transfer of patients’ 
education to pharmacists. 
One chronic disease. Patient 
education. Enhancement of the 
outcome. 
Periodical use of the 
model. 
DM 
 
 
- 
 
Complexified communi-
cation.  
No possibility to request further 
analyses and prescriptions.  
Non-inclusion of social 
workers.  
ACO – Accountable Care Organisations; PCMH – Patient Centred Medical Home; MTM – Medication Therapy 
Management; DM – Disease Management. 
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Table 2b 
Analysis of the most represented healthcare and social collaborative practice models  
– elderly and system perspective 
Collaborative practice 
model – elderly 
Scope of the 
model 
Patient/elderly people System/payers of services 
 
 
Organisations of healthcare providers, who agreed on the payment based on the 
performance of services provided. Such organisations focus on the most positive 
outcomes for their patients and function within the Medicare programme.  
+ 
 
Full healthcare service in one 
place. Plenty of time is dedicated to 
patients. 
Directing the costs of system to a third 
party.  
ACO 
(organisations of 
healthcare providers) 
- 
 
A small number of patients are able 
to afford this type of healthcare. 
It is necessary to include the third party as 
the payer, i.e., private funds. 
 
 
Focused on a team, collocated therapy for chronic diseases. Developed as a result 
of a lack of physicians. Includes teams composed of physicians, pharmacists, so-
cial workers, nurses, carers, nutritionists, etc. Provides outpatient services mainly. 
+ 
 
Patients is able to receive the full 
healthcare and social service at 
their home. 
A holistic approach to the condition of the 
patient reduces the costs by decreasing the 
likelihood of administering the wrong ther-
apy.  
PCMH 
(healthcare services 
provided at patient’s 
home) 
- May disturb the peace and privacy 
of other tenants.  
Increased costs for the system. Work of the 
organisation gets complicated and travel 
costs are higher. 
 Medication Therapy Management including greater involvement of pharmacists in 
patient’s therapy, both in pharmacies and on site. It includes: analysis of medica-
tion therapy, pharmacotherapeutic consultation, anticoagulation therapy manage-
ment, immunisation, health and wellness programmes. 
+ 
 
A patient does not have to visit a 
physician to get the prescription for 
a chronic disease therapy.  
Reducing the workload of physicians who 
are often unavailable. Reducing the time 
and procedure for receiving the appropriate 
therapy.  
MTM 
 
- 
 
Possible non-determination of the 
designated pharmacist who would 
monitor the patient’s condition for 
a longer period of time.  
More complicated payment and valorisation 
of the additional work.  
 
 
Education of patients about medications, continuous monitoring (by the physician 
and pharmacist) of patients with highly prevalent chronic conditions; in case of 
several treatment modalities; a possibility of self-care; carrying a significant eco-
nomic burden. Multiway communication. 
+ 
 
Patients are provided with the nec-
essary education on diseases at the 
pharmacy. 
Reducing costs for an organisation and 
making appointments. Increase in potential 
loss of earnings for employees due to long 
waiting periods at the physician’s.  
DM 
 
- 
 
Traditionally, patients have more 
confidence in physicians. Ensuring 
one’s privacy. 
The system is generally not familiar with 
provision of these additional services by 
pharmacists.  
ACO – Accountable Care Organisations; PCMH – Patient-Centred Medical Home; MTM – Medication Therapy Manage-
ment; DM – Disease Management. 
 
 
 
Consideration of the proposed conceptual model of col-
laborative healthcare and pharmacy practice in elderly 
healthcare and social care  
The conceptual model presented in Figure 2 suggests a 
holistic approach to the implementation of collaborative 
models that must be considered in a multi-way manner 
where each phase represents the activity already completed 
in previous phases. Therefore, the very analysis of the pro-
posed conceptual model should be approached from all di-
rections and in a multi-way manner, representing the natural 
dynamics of the system. Certainly, it should be emphasised 
at the very beginning of the analysis that the system of 
healthcare and social care could still function traditionally 
independently. In such case, any form of collaboration, in 
terms of its continuity and planned organisation, is actually 
made impossible. However, it might still be possible for a 
physician to call a pharmacist by the phone for an eventual 
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consultation regarding a particular medication, respecting 
his/her expertise in pharmacology. Nevertheless, that case 
does not constitute a form of collaborative practice, but actu-
ally a traditional isolated form of the healthcare practice. 
This case is presented in the bottom left corner of the pyra-
mid in Figure 2. It represents a negative value (absence of a 
collaborative practice), if the pyramid is considered a coor-
dinate system. Anything occurring prior to the origin is a 
number of preliminary activities that need to be undertaken, 
with a clear intention of having a collaborative association 
for enabling a collaborative practice to begin with. More de-
tails on the preliminary activities of collaboration were dis-
cussed by Bradley et al. 7, so the proposed conceptual model 
shown in Figure 2 does not describe them. Traditional isola-
tion at the ground zero is followed by an initiation phase 
(provided there is a team cooperation aspiration). The initia-
tion phase continues further and coincides with the phase of 
communication and collaboration. The highest level com-
prises the phase of integration of all providers of the health-
care and social care services and the system/payers. 
Disease Management (DM) provides education to pa-
tients regarding medications and continuous monitoring of 
chronic diseases. It may be organised within a pharmacy, and 
represent a healthcare collaboration only. Although regular 
activities of pharmacists include consultation services about 
medications, DM comprises certain monitoring activities and 
supervision of chronic conditions of a particular patient. 
Educational seminars could also be organised in a planned 
manner, for a particular type of chronic disease on pharmacy 
premises, in a form of informative and confidential work-
shop. The same form of organisation may be used within a 
health centre, i.e., at the primary level of healthcare. Collabo-
ration in disease management often includes delegating tra-
ditional activities of physicians to pharmacists (monitoring 
of chronic diseases), or, on the other hand, a joint association 
for organised consultations. 
 
 
 
Fig. 2 – Conceptual model of collaborative healthcare and pharmacy practice in healthcare  
and social care for the elderly. 
IM – Intergrative model; PEMH – Patient-Centred Medical Home; MTM – Medication Therapy 
Management; DM – Disease Management; HCM – Hospital Case Management. 
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Medication Therapy Management (MTM) is certainly 
the most thoroughly described model of the collaborative 
healthcare practice in relevant literature. MTM ensures an 
active participation of pharmacists in a therapy. Implemen-
tation of this model includes establishment of a very high 
level of inter-professional communication. It often happens 
that a pharmacist becomes an administrator of medications 
for a chronic disease (when the complete therapy manage-
ment may be performed by a pharmacist, and following the 
diagnosis established by a physician) after taking an addi-
tional year of education at a faculty of medicine. In this 
model of the collaborative healthcare practice, a significant 
responsibility is given to the system/payers, which is/are 
required to establish a functional payment system for addi-
tional services provided by the pharmacists. If the very 
MTM is considered, patients could encounter this model at 
the pharmacy. In this phase of explanation of the collabora-
tive model, it should be noted that MTM may be an integral 
part of Patient Centred Medical Home (PCMH) and a part 
of an Integrated Model, while the MTM would always in-
clude DM as well. Due to such a connection between a dis-
ease management and medication therapy models, these 
two constitute the hospital Case Menagment (HCM) model 
of collaborative practice of healthcare workers, because 
they are allowed to organise themselves independently 
from the social workers. 
PCMH is a model of team organisation and provision of 
healthcare and social care services at patient`s homes. This 
form of practice is mainly focused on the elderly, those with 
difficulty walking and/or persons whose homes are located 
far away from the healthcare facilities (primary or secondary 
level). Patients/elderly people may use this model in their 
own homes, when a collaborative team visits them upon con-
firming the visit. It is obvious at this level that this model in-
cludes social care for the elderly in addition to the healthcare 
(as shown in a pyramid in Figure 2). Besides the healthcare 
workers (e.g.: physicians, pharmacists, nurses, therapists, 
etc.), the PCMH model teams also involve the social work-
ers, who visit the homes of elderly persons and provide them 
with a range of necessary healthcare and social services as 
well. This model includes both MTM and DM. 
The Integrative Model (IM) is a model with the highest 
level of collaboration. Actually, the IM is generally used as 
the Accountable Organisations (ACO) model, functioning 
within the Medicare. In addition to the health and social care, 
this level of collaborative practice includes a payer, i.e., the 
third party (mainly private funds) and naming it an integra-
tive model was quite logical. The patient goes to an organi-
sation – a health facility where he/she is provided with a full 
collaborative service. The model relies on a high level of 
communication, often supported by information systems, 
which connects all members of the team, who keep a joint 
record on the patient/beneficiary. 
The conceptual model comprises both: pull and push 
strategies, or learning about the system needs for collabora-
tive models and their support as well as a promotion of col-
laborative models and establishing positive regulatory provi-
sions, etc. In this respect, it is obvious that the system func-
tions in a multi-way manner, but primarily from the top of 
the pyramid (regulations and regulators) towards the bottom 
of the pyramid as shown in Figure 2. 
Stimulations and obstacles to collaborative practice in 
geriatric care 
Individual ageing is a natural and inevitable process 
that we all face constantly. Population ageing, unlike the 
previous one, is a unique phenomenon in a demographic 
history of mankind caused primarily by industrial, sexual 
revolution and absorption of women into the labour mar-
kets. Its ultimate outcomes, increased early childhood sur-
vival combined with the extended longevity in most nations 
jointly contribute to the growing share of elderly citizens in 
most contemporary societies 18. Those demographic trends 
of further population ageing are present in  European coun-
tries, and represent one of the greatest challenges encoun-
tered in the healthcare, social and economic systems of 
those countries. According to the Eurostat 19 information 
from 2014, the population above the age of 65 would in-
crease approximately 50%, from 18.2% at the time (data 
from 2013) to 28.1% by 2050. In this respect, the share of 
the working-age population would also change, and thus, 
according to the current trends, by 2050, the ratio between 
the working-age population and population above the age 
of 65 would decrease from the current rate of 4 : 1 to 
2 : 1 19. Therefore, in addition to a higher life-expectancy 
for the population 20, the age limit for working-age popula-
tion would also change, and so the healthcare system for 
the elderly would have to operate at a higher system per-
formance level 21. This situation puts a positive pressure on 
the healthcare and social care systems regarding developing 
new and innovative models to be able to adequately re-
spond to growing demands set before the healthcare and 
social care systems for the elderly. Taking into account that 
visibility of older people in rural area is even lower than 
the visibility of older people in urban areas, which is corre-
lated with higher depression of older people in rural than in 
urban areas 22, it is highly important to achieve functional 
MTM collaborative practice, especially in rural areas. Due to 
that, a holistic approach to perceiving the problems shared by 
the aforementioned systems produced several collaborative and 
inter-professional models of pharmacy practice within the 
healthcare and social care for the elderly.  
Collaborative practice in the field of geriatric care takes 
place in most cases only upon establishing some of the 
healthcare collaborative practice models as described above. 
Therefore, it should not come as a surprise that only few pa-
pers discuss this topic, although the importance of collabora-
tion in geriatric care is unquestionable. The paper by Young 
et al. 23 is listed in the literature as a reference paper for es-
tablishing the foundations and guidelines for a further re-
search into the problem of collaboration in the field of geriat-
ric care. Young et al. 23 provided their contribution to the 
given sensitive issue by summing up all the stimulating and 
restricting factors encountered by the collaborative practice 
in the field of geriatric care. 
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Conclusion 
The proposed collaborative practice model integrates 
dynamically the most represented models of the collabora-
tive practice in the healthcare and social care for the elderly, 
providing a new insight into the described models from the 
perspective of service providers, patients/elderly people and 
systems/payers. Additionally, it is necessary to ensure under-
standing of multi-way relations within collaborative practice 
models (with healthcare and social care systems both of the 
payer and the regulator, as active participants in the back-
ground). Thus, a conceptual model should be considered 
prior to the actual implementation of the model of the col-
laborative practice in the healthcare and social care for the 
elderly, within the system of a country, in order to be more 
certain about selecting the models and activities that need to 
be undertaken in order to achieve the preferred effects gener-
ated from the collaborative practice. 
If one considers the implementation of a collaborative 
model of the healthcare and social care practice by focusing 
on the elderly, the course of action should be based on an ef-
ficient overcoming of challenges as well as the establishment 
of a primary model of Medication Therapy Management in 
phases. Subsequently, the collaborative practice should be 
extended to include the implementation of the PCMH model 
which is the most significant model for the elderly popula-
tion. Certainly, the basis for each model of collaborative 
practice focusing on the elderly is the pharmacy collabora-
tive practice. That is why the pharmacy collaborative prac-
tice is the unavoidable, initial and conditional (conditio sine 
qua non) basis for the collaborative practice model focusing 
on the elderly. 
Finally, it may be useful to conclude once again, that by 
inclusion of a positive regulatory pressure, together with an 
efficient implementation of the payment model for the col-
laborative pharmacy practice, all other obstacles on the path 
of implementing a collaborative pharmacy model should be 
overcome, taking into account the positive attitude towards 
the collaborative practice shared by a society, healthcare and 
social care professionals. 
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